Global Self Storage to Present at the 29th Annual ROTH Conference on March 15, 2017
Mar 06, 2017 13:31 pm UTC| Business
NEW YORK, March 06, 2017 -- Global Self Storage, Inc. (NASDAQ:SELF), a real estate investment trust (REIT) that owns and operates self storage facilities, has been invited to present at the29th Annual ROTH investor...
Global Self Storage to Present at the 29th Annual ROTH Conference on March 15, 2017
Mar 06, 2017 13:31 pm UTC| Business
NEW YORK, March 06, 2017 -- Global Self Storage, Inc. (NASDAQ:SELF), a real estate investment trust (REIT) that owns and operates self storage facilities, has been invited to present at the29th Annual ROTH investor...
Aptevo Therapeutics to Present at the 29th Annual ROTH Conference
Mar 06, 2017 13:30 pm UTC| Business
SEATTLE, March 06, 2017 -- Aptevo Therapeutics Inc. (Nasdaq:APVO), a biotechnology company focused on developing novel oncology and hematology therapeutics, today announced that management will be presenting at the 29th...
Landec Corporation to Present at the 29th Annual ROTH Conference
Mar 06, 2017 13:30 pm UTC| Business
MENLO PARK, Calif., March 06, 2017 -- Landec Corporation (NASDAQ:LNDC), a leading innovator of diversified health and wellness solutions within the packaged food and biomaterial markets, announced today that Molly...
Evoke Pharma Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares
Mar 06, 2017 13:30 pm UTC| Business
SOLANA BEACH, Calif., March 06, 2017 -- Evoke Pharma, Inc. (Nasdaq:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal diseases, announced today that the underwriter of its previously...
Sonendo® to Present at 29th Annual ROTH Conference
Mar 06, 2017 13:30 pm UTC| Business
LAGUNA HILLS, Calif., March 06, 2017 -- Sonendo® Inc. the developer of a breakthrough technology for the dental marketplace, announced today that it will be presenting at the upcoming 29thAnnual ROTH Conference in Dana...
Mar 06, 2017 13:30 pm UTC| Business
WALTHAM, Mass., March 06, 2017 -- Minerva Neurosciences, Inc. (NASDAQ:NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today...